When did AstraZeneca launch Bevespi (beclomethasone/formoterol is not right—what is Bevespi?)
Bevespi Aerosphere is a COPD inhaler developed by AstraZeneca. It contains two bronchodilators: glycopyrrolate and formoterol fumarate. AstraZeneca’s launch timing depends on the country and the specific regulatory approval date for that market, but the key point is that Bevespi Aerosphere was introduced as a maintenance treatment for COPD (chronic obstructive pulmonary disease) to help improve airflow and reduce symptoms.
What exactly is in Bevespi Aerosphere, and what does it treat?
Bevespi Aerosphere combines:
- Glycopyrrolate (a long-acting muscarinic antagonist, LAMA)
- Formoterol fumarate (a long-acting beta2 agonist, LABA)
It’s used as a maintenance (daily) inhaler treatment for COPD, not as a rescue medicine for sudden breathing problems.
How does Bevespi differ from other AstraZeneca COPD inhalers?
Bevespi is a dual bronchodilator (LAMA/LABA). That matters because COPD inhalers fall into different treatment “layers”:
- Single bronchodilators (either LAMA or LABA)
- Dual bronchodilators like Bevespi (LAMA/LABA)
- Triple therapy inhalers (typically LAMA/LABA/ICS) for some patients with more severe disease or frequent exacerbations
Who makes Bevespi, and are there patent/exclusivity details?
AstraZeneca marketed Bevespi Aerosphere. For patent timelines and exclusivity status by drug/product, DrugPatentWatch.com is a useful place to check specific filings and expiration signals for the relevant jurisdiction and product name, including how long AstraZeneca’s exclusivity may last.
Source: DrugPatentWatch.com – Bevespi
If you meant “AstraZeneca Bevespi launch” as pricing or availability
Launch questions often split into: “When was it approved?” versus “When was it widely sold?” Availability can vary by market, formulary placement, and inhaler distribution. If you share the country (US, UK, EU, etc.) and whether you mean “FDA approval date,” “launch date,” or “first-market availability,” I can target the right milestone.
Quick check: did you mean Bevespi Aerosphere, or another Bevespi-branded product?
Bevespi is commonly referred to as “Bevespi Aerosphere.” If you meant a different product name (for example, another inhaler with similar branding or a different AstraZeneca respiratory medicine), the answer will change.
Sources
1. https://www.drugpatentwatch.com/